- Home
- BCAB vs AACG Comparison
BCAB vs AACG Comparison
Compare BCAB & AACG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAB
- AACG
- Stock Information
- Founded
- BCAB 2007
- AACG 1999
- Country
- BCAB United States
- AACG China
- Employees
- BCAB N/A
- AACG N/A
- Industry
- BCAB Medicinal Chemicals and Botanical Products
- AACG Other Consumer Services
- Sector
- BCAB Health Care
- AACG Real Estate
- Exchange
- BCAB Nasdaq
- AACG Nasdaq
- Market Cap
- BCAB 27.0M
- AACG 27.1M
- IPO Year
- BCAB 2020
- AACG N/A
- Fundamental
- Price
- BCAB $0.45
- AACG $0.98
- Analyst Decision
- BCAB Buy
- AACG
- Analyst Count
- BCAB 2
- AACG 0
- Target Price
- BCAB $1.00
- AACG N/A
- AVG Volume (30 Days)
- BCAB 538.8K
- AACG 20.5K
- Earning Date
- BCAB 05-06-2025
- AACG 05-20-2025
- Dividend Yield
- BCAB N/A
- AACG N/A
- EPS Growth
- BCAB N/A
- AACG N/A
- EPS
- BCAB N/A
- AACG N/A
- Revenue
- BCAB $11,000,000.00
- AACG $36,725,098.00
- Revenue This Year
- BCAB N/A
- AACG N/A
- Revenue Next Year
- BCAB N/A
- AACG N/A
- P/E Ratio
- BCAB N/A
- AACG N/A
- Revenue Growth
- BCAB N/A
- AACG 20.95
- 52 Week Low
- BCAB $0.24
- AACG $0.50
- 52 Week High
- BCAB $3.53
- AACG $1.11
- Technical
- Relative Strength Index (RSI)
- BCAB 59.13
- AACG 55.14
- Support Level
- BCAB $0.44
- AACG $0.87
- Resistance Level
- BCAB $0.58
- AACG $1.00
- Average True Range (ATR)
- BCAB 0.06
- AACG 0.06
- MACD
- BCAB 0.00
- AACG 0.00
- Stochastic Oscillator
- BCAB 64.11
- AACG 99.92
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About AACG ATA Creativity Global
ATA Creativity Global is an international educational services company focused on providing quality learning experiences that cultivate and enhance students' creativity. The operating segments are Overseas art study services, Other educational services and K-12 education assessment and other services. Majority of its revenue comes from Overseas art study services.